Sicart Associates’s Cerence CRNC Stock Holding History

Sicart Associates’s Portfolio CRNC Stock Details CRNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-14,027	Closed	-$216K	–	112
2020 Q1	$216K	Sell	14,027 -694	-5%	-$14.6K	0.08%	89
2019 Q4	$333K	Buy	+14,721	New	+$241K	0.11%	82

Other funds holding CRNC

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Isomer Partners New York $74.3M AUM 23.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Sicart Associates's CRNC Position: Q2 2020 in Review

Sicart Associates sold out of Cerence (CRNC) in Q2 2020, closing a stake of 14,027 shares — an estimated $216K sold.

Sicart Associates first reported a position in CRNC in Q4 2019 and held it in 2 quarters. The position peaked at $333K in Q4 2019. 241 funds tracked by Wall St. Rank hold CRNC as of Q2 2020.

Sicart Associates reported no remaining Cerence position as of Q2 2020 after selling out during the quarter.
Sicart Associates sold 14,027 Cerence shares in Q2 2020, an estimated $216K.
Sicart Associates first reported a position in Cerence in Q4 2019 and held it in 2 quarters.
Sicart Associates's Cerence position peaked at $333K in Q4 2019.
241 funds tracked by Wall St. Rank held Cerence as of Q2 2020.

Based on Sicart Associates's 13F filing for Q2 2020, filed 30 Jul 2020.